| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 09/19/2002 | US20020132842 Substituted benzimidazoles, processes for their preparation, their use as medicaments, and medicaments comprising them |
| 09/19/2002 | US20020132833 Caspase inhibitors and uses thereof |
| 09/19/2002 | US20020132822 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 09/19/2002 | US20020132820 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 09/19/2002 | US20020132810 Novel heterocyclic amide derivatives |
| 09/19/2002 | US20020132809 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production |
| 09/19/2002 | US20020132763 Deuterated cyclosporine analogs and their use as immunomodulating agents |
| 09/19/2002 | DE10110754A1 Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use |
| 09/19/2002 | DE10110438A1 Substituierte 2-Oxy-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and their use |
| 09/19/2002 | DE10058461A1 Substituierte Cyclohexanderivate und ihre Verwendung Substituted cyclohexane derivatives and their use |
| 09/19/2002 | CA2473979A1 Method for identifying inhibitors of g protein coupled receptor signaling |
| 09/19/2002 | CA2441082A1 Steap-related protein |
| 09/19/2002 | CA2440773A1 Novel mhc molecule constructs, and methods of employing these constructs for diagnosis and therapy, and uses of mhc molecules |
| 09/19/2002 | CA2440555A1 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
| 09/19/2002 | CA2440225A1 Taxane prodrugs |
| 09/19/2002 | CA2439612A1 Modulation of smooth muscle cell proliferation |
| 09/19/2002 | CA2438586A1 Retinoid x receptor modulators |
| 09/19/2002 | CA2437963A1 Therapeutic binding molecules |
| 09/19/2002 | CA2437958A1 Polymeric immunoglobulin fusion proteins that target low-affinity fc.gamma.receptors |
| 09/18/2002 | EP1241170A2 Pyrazolopyrimidine derivatives |
| 09/18/2002 | EP1240321A2 MODULATION OF i PAX /i -2 FOR CONTROLLED APOPTOSIS OR SURVIVAL OF CELLS |
| 09/18/2002 | EP1240202A2 Inhibitors of complement activation, their preparation and use |
| 09/18/2002 | EP1240197A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 09/18/2002 | EP1240152A1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors |
| 09/18/2002 | EP1240146A1 2-arylquinoline derivatives, preparation and therapeutic use thereof |
| 09/18/2002 | EP1240145A2 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof |
| 09/18/2002 | EP1239870A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 09/18/2002 | EP1239867A2 Methods for treating and preventing damage to mucosal tissue |
| 09/18/2002 | EP1239854A1 Use of a hypoglycemic agent for treating impaired glucose metabolism |
| 09/18/2002 | EP1239845A2 Hydroxide-releasing agents as skin permeation enhancers |
| 09/18/2002 | EP1056461B1 Glucocorticoids for treating glomerulonephritis |
| 09/18/2002 | EP1000034B1 Substituted 6-alkylphenanthridines |
| 09/18/2002 | EP0934259B1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 09/18/2002 | EP0904260B1 Inhibition of matrix metalloproteases by 2-(omega-aroylalkyl)-4-biaryl-oxobutyric acids |
| 09/18/2002 | EP0823889B1 1,3-propane diol derivatives as bioactive compounds |
| 09/18/2002 | EP0575357B1 Human follicle stimulating hormone receptor |
| 09/18/2002 | CN1370238A Human poly(ADP-ribose) polymerase 2 materials and methods |
| 09/18/2002 | CN1370175A Dithiepino [6,5-b] pyridines, and related compsns. and methods |
| 09/18/2002 | CN1370174A 2,3-benzodiazepine derivatives |
| 09/18/2002 | CN1370173A Isomeric fused pyrrolocarbazoles and isoindolones |
| 09/18/2002 | CN1370163A Imidazo [1,2-A] pyridine and pyrazolo [2,3-a] pyridine derivatives |
| 09/18/2002 | CN1370159A Indole derivatives and their use for treatment of osteoporosis amongst other applications |
| 09/18/2002 | CN1370146A Alpha/Beta integrin inhibitors |
| 09/18/2002 | CN1369303A Medicine for treating chronic nephritis |
| 09/18/2002 | CN1090948C Medicine powder for prostatitis |
| 09/18/2002 | CN1090946C Health medicine for tonifying spleen and removing dampness heat |
| 09/17/2002 | US6452044 Benzenedicarboxylic acid derivatives |
| 09/17/2002 | US6452001 1,4-diazepine-2-one derivatives as neurokinin antagonist |
| 09/17/2002 | US6451994 Polypeptides, polynucleotides; drug screening; diagnosing alzheimer*s, parkinson*s, huntington*s, and creutzfelt-jacob disease; amyotrophic lateral sclerosis, cystic fibrosis |
| 09/17/2002 | US6451859 C16 unsaturated FP-selective prostaglandins analogs |
| 09/17/2002 | US6451849 Use of hydroxymatairesinol for prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol |
| 09/17/2002 | US6451842 Cyclic amine derivatives and their use as drugs |
| 09/17/2002 | US6451838 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 09/17/2002 | US6451817 Alpha-substituted-1-benzyl-napthyls |
| 09/17/2002 | US6451804 Heteroalkylamino-substituted bicyclic nitrogen heterocycles |
| 09/17/2002 | US6451791 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/17/2002 | US6451780 Progesterone antagonists for the production of pharmaceutical agents for the treatment of dysfunctional uterine bleeding |
| 09/17/2002 | US6451577 Human uridine disphosphate galactose-4-epimerase |
| 09/17/2002 | CA2243459C Human antibodies that bind human tnf.alpha. |
| 09/16/2002 | CA2376844A1 Pyrazolo¢4,3-d!pyrimidin-7-ones and pyrazolo¢3,4!pyrimidin-4-ones and purinones which inhibit cgmp pdes |
| 09/12/2002 | WO2002070706A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 09/12/2002 | WO2002070676A2 Use of protein histidine phosphatase |
| 09/12/2002 | WO2002070669A2 Secreted proteins |
| 09/12/2002 | WO2002070565A2 High-affinity antagonists of elr-cxc chemokines |
| 09/12/2002 | WO2002070563A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070562A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070561A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070560A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070559A2 Nuclear hormone receptor ligand binding domains |
| 09/12/2002 | WO2002070558A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070557A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070525A2 Nitrogen-based camptothecin derivatives |
| 09/12/2002 | WO2002070523A1 Modulators of chemokine receptor activity |
| 09/12/2002 | WO2002070515A2 Chromane derivatives, process for their preparation and their use as antitumor agents |
| 09/12/2002 | WO2002070514A1 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists |
| 09/12/2002 | WO2002070511A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 09/12/2002 | WO2002070509A2 Antagonists of mcp-1 function and methods of use thereof |
| 09/12/2002 | WO2002070502A1 Dimeric isoflavones |
| 09/12/2002 | WO2002070500A1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as ip antagonists |
| 09/12/2002 | WO2002070493A1 Bisaryl derivatives having fsh receptor modulatory activity |
| 09/12/2002 | WO2002070485A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 09/12/2002 | WO2002070484A1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof |
| 09/12/2002 | WO2002070479A1 N-4-piperidinyl compounds as ccr5 modulators |
| 09/12/2002 | WO2002070473A2 Carboxamide derivatives as therapeutic agents |
| 09/12/2002 | WO2002070461A1 Side-chain halogenated amino carboxylic acid derivatives as medicaments for treating cardiovascular diseases |
| 09/12/2002 | WO2002070459A1 Novel amino dicarboxylic acid derivatives |
| 09/12/2002 | WO2002070457A1 Inhibitor of monoamine uptake |
| 09/12/2002 | WO2002069998A1 Regulating vegf expression by a protein of the tis11 family |
| 09/12/2002 | WO2002069980A2 Pharmaceutically effective ginsenosides and their use |
| 09/12/2002 | WO2002069970A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 09/12/2002 | WO2002069965A1 Benzimidazole derivatives as therapeutic agents |
| 09/12/2002 | WO2002069906A2 Compounds and methods for the treatment of urogenital disorders |
| 09/12/2002 | WO2002069886A2 Modified proteins, designer toxins, and methods of making thereof |
| 09/12/2002 | WO2002069883A2 Cathecin derivatives as leukocyte elastase inhibitors for treating inflammatory disorders |
| 09/12/2002 | WO2002063010A9 Method of producing recombinant antibodies against tumors |
| 09/12/2002 | WO2002028859A3 Condensed pyridoindole derivatives |
| 09/12/2002 | WO2001009192A9 Human monoclonal antibodies to prostate specific membrane antigen |
| 09/12/2002 | US20020128481 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 09/12/2002 | US20020128471 Useful for treating cellular hyperproliferation |
| 09/12/2002 | US20020128287 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents |